Celeste Rachelle Fralick - Mar 31, 2025 Form 4 Insider Report for Aspira Women's Health Inc. (AWH)

Role
Director
Signature
/s/ Celeste Rachelle Fralick
Stock symbol
AWH
Transactions as of
Mar 31, 2025
Transactions value $
$0
Form type
4
Date filed
4/1/2025, 06:42 PM
Previous filing
Jan 8, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AWH Common Stock Options Exercise $0 +5K +9.87% $0.00 55.7K Mar 31, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AWH Restricted Stock Units Options Exercise $0 -5K -50% $0.00 5K Mar 31, 2025 Common Stock 5K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Celeste Rachelle Fralick is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 20,000 RSUs, 5,000 of which vested on March 31, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024.
F2 Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock.
F3 On August 22, 2024, the reporting person was granted 20,000 RSUs, 5,000 of which vested on March 31, 2025. The common stock into which such vested RSUs converted on March 31, 2025 is reported in Table I on this Form 4.